[Chemotherapy in malignant gliomas]
- PMID: 2293042
- DOI: 10.1055/s-2008-1053590
[Chemotherapy in malignant gliomas]
Abstract
Considering the survival time of patients with malignant gliomas indication for chemotherapy in spite of side effects is recommended. One third of them are living 2 years, some even longer. Before starting such a treatment a critical evaluation is mandatory, a prolongation of dying must be avoided. In addition personal human care to the patient and his family has a great importance.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical